Glaukos (GKOS) reported a Q2 adjusted loss late Wednesday of $0.14 per diluted share, narrowing from a loss of $0.24 a year earlier.
Analysts polled by FactSet expected a loss of $0.21.
Revenue for the three months ended June 30 was $185.6 million, up from $124.1 million a year earlier.
Analysts expected $150.9 million.
For the full-year 2026, the company now expects revenue of $680 million to $700 million, compared with $620 million to $635 million previously.
Analysts expect $630 million.